SNBL Clinical Pharmacology Center, Inc.
SNBL Clinical Pharmacology Center, Inc. is a 96-bed, state-of-the-art, Phase I/IIa Clinical Pharmacology Center. SNBL partners with pharmaceutical companies to accelerate product development through early stage clinical trials and supports complex, multi-faceted Phase I Programs designed to understand the science behind human safety and tolerability. SNBL’s parent company, Shin Nippon Biomedical Laboratories, Ltd. (SNBL), was founded in 1957 in Kagoshima, Japan. The company maintains branches and subsidiary companies in Japan, the United States, China, and Europe, with more than 1,100 employees worldwide.